Clinical trials
Phase 1 Hematologic Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Antengene Discovery Limited | 1 |
| Antengene Therapeutics Limited | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Atridia Pty Ltd. | 1 |
| Hutchison Medipharma Limited | 1 |
| Incyte Corporation | 1 |
| Janssen Research & Development, LLC | 1 |
| MacroGenics | 1 |
| Novartis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 13 |
| Lymphoma, Non-Hodgkin | 3 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, T-Cell | 2 |
| Recurrence | 2 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
| Cholangiocarcinoma | 1 |
| Hodgkin Disease | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.